Antibody Engineering for Therapeutic Applications
Explore the latest advancements in antibody engineering and its potential in developing effective therapies. Learn about protein sequences, structure, and design strategies.
Antibody Engineering for Therapeutic Applications
E N D
Presentation Transcript
VHCDR-1 CDR-2 1 E V Q L V E S G G G L V Q P G G S L R L S C A A S G F T F S S Y A* * * * M S W V R Q A P G K G L E W V S A I S G S G G S T * * *C1 1 E V Q L V E S G G G L V Q P G G S L R L S C A G S G F T F S S Y A * * * * M H W V R Q A P G K G L E W V S A I G T G G G T * * * * D11 1 E V Q L V E S G G G L V Q P G G S L R L S C A A G G F T F S S Y A * * * * M H W V R Q A P G K G L E W V S A I G T G G G T * * * * A 8 CDR-3 63 Y Y A D S V K G R F T I S R D N S K N T L Y L Q M N S L R A E D T A V Y Y C A R S D A A G N P S R * * *W G Q G T L V T VC1 62 Y Y A D S V K G R F T I S R D N A K N S L Y L Q M N S L R A E D T A V Y Y C A R NR G A P G I D K V T* W G Q G T L V T V D11 62 Y Y A D S V K G R F T I S R D N A K N S L Y L Q M N S L R A E D T A V Y Y C A RL W G R A S S T Q E P N W G Q G T L V T V A8 VL CDR-1 CDR-2 1 S S E L T Q D P A V S V A L G Q T V R I T C Q G D S L R S Y Y * * * * * * A S W Y Q Q K P G Q A P V L V I Y G K N N * * * * * * * C1 CDR-3 54 R P S G I P D R F S G S S S G N T A S L T I T G A Q A E D E A D Y Y C N S R D S S G N H A Y V F G G G T K L T V L G C1
